PDS Biotechnology Corporation

NasdaqCM:PDSB

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

💉 Vaccines

Location

United States

Market Cap

USD 49.37 M

Share Price

USD 1.08

Avg Daily Volume

591,488

Change (1 day)

-2.70%

Change (1 year)

-64.47%

Change (YTD)

-33.74%

PDS Biotechnology Corporation Return on Assets (ROA) for the Trailing 12 Months (TTM) ending August 13, 2025: N/A

PDS Biotechnology Corporation Return on Assets (ROA) is NA for the Trailing 12 Months (TTM) ending August 13, 2025. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Competitors

Eli Lilly and Company

USD 635.22

LLY

+9.57 1.53%

AbbVie Inc.

USD 198.64

ABBV

+0.59 0.30%

Roche Holding AG

USD 317.50

RO.SW

-1.30 -0.41%

AstraZeneca PLC

USD 150.15

AZN.L

-2.01 -1.32%

Novartis AG

USD 117.98

NOVN.SW

+1.67 1.43%

Novo Nordisk A/S

USD 50.09

NOVO-B.CO

-0.18 -0.35%

Merck & Co., Inc.

USD 80.03

MRK

-0.66 -0.82%

Thermo Fisher Scientific Inc.

USD 462.39

TMO

+1.67 0.36%

Amgen Inc.

USD 285.09

AMGN

-3.14 -1.09%

Gilead Sciences, Inc.

USD 120.47

GILD

+1.06 0.89%

Pfizer Inc.

USD 24.58

PFE

0.00%

Sanofi

USD 94.48

SAN.PA

+0.27 0.29%

Vertex Pharmaceuticals Incorporated

USD 374.46

VRTX

+7.92 2.16%

Bristol-Myers Squibb Company

USD 45.93

BMY

-0.02 -0.04%

Chugai Pharmaceutical Co., Ltd.

USD 41.68

4519.T

+0.46 1.11%

View all

Key Data

Date	Return on Assets (ROA)	Revenue Per Share	Free Cash Flow Per Share	Dividend Per Share